Skip to main content
TipRanks
Go Ultimate75% OFF

Medinex Ltd. (OTX) AI Stock Analysis

3 Followers
SG:OTX

Medinex Ltd.

(SGX:OTX)

Select Model
Rating:78Outperform
Price Target:SGD 0.23▲(14.00% Upside)
Action:reiterated
Date:10/14/26

The score is driven primarily by strong financial stability (notably low leverage) and attractive valuation (low P/E and high dividend yield). These positives are tempered by softer recent operating momentum, including the 2026 revenue decline, margin step-down, and weaker free cash flow, while technicals are moderately supportive with mixed momentum signals.

Positive Factors
Conservative balance sheetVery low leverage gives Medinex substantial financial flexibility and reduces the burden of interest and refinancing costs. A strong equity base should help the company withstand operating volatility while preserving capacity to support investment, dividends, or other capital-allocation priorities.
Negative Factors
Recent revenue contractionThe latest revenue decline indicates that operating momentum has weakened and that recent growth has not yet become consistent. If the contraction persists, a smaller revenue base could limit operating leverage, reduce reinvestment capacity, and make future profit improvement more dependent on cost control.

Medinex Ltd. (OTX) vs. iShares MSCI Singapore ETF (EWS)

-20%-10%0%10%20%30%SG:OTX-10.31%EWS+12.47%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SGD 23.92M
Dividend Yield
8.40%
Average Volume (3M)
33.13K
Price to Earnings (P/E)
7.9
Beta (1Y)
0.21
Revenue Growth
-3.11%
EPS Growth
-21.50%
Country
Singapore
Employees
65
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Medinex Ltd. Business Overview & Revenue Model

Company Description

Medinex Limited, an investment holding company founded in Singapore in 2009, specializes in providing extensive professional support services, primarily catering to medical clinics across the country. The company's operations are divided into four ma...

Medinex Ltd. Financial Statement Overview

Summary

Strong underlying profitability and a very conservative balance sheet support a solid financial score. Offsetting this, revenue declined in 2026 (-3.1%), net margin softened (22.1% to 17.9%), and free cash flow fell sharply in 2026 (~-23.3%), indicating less consistent growth and cash-flow momentum.

Income Statement

72Positive

Balance Sheet

86Very Positive

Cash Flow

68Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue15.51M12.41M12.81M12.58M12.97M10.79M
Gross Profit5.44M9.96M9.93M9.68M9.48M3.31M
EBITDA3.84M2.99M3.58M1.79M2.88M2.24M
Net Income3.92M2.22M2.83M1.03M1.70M3.49M
Balance Sheet
Total Assets19.47M19.47M20.69M20.50M22.59M23.43M
Cash, Cash Equivalents and Short-Term Investments5.61M5.52M5.56M5.17M4.15M6.73M
Total Debt996.00K996.00K1.67M2.08M2.34M3.95M
Total Liabilities2.95M2.95M3.96M4.34M4.81M6.50M
Stockholders Equity16.52M16.52M16.72M16.12M17.57M16.66M
Cash Flow
Free Cash Flow3.37M2.55M3.33M2.67M2.83M2.96M
Operating Cash Flow3.45M2.71M3.35M2.70M3.03M3.04M
Investing Cash Flow366.38K670.00K243.45K1.66M-2.19M-2.61M
Financing Cash Flow-5.07M-3.41M-3.20M-3.33M-3.02M748.53K

Medinex Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.20

Price Trends

50DMA0.21Negative
100DMA0.21Negative
200DMA0.22Negative

Market Momentum

MACD-0.00Positive
RSI46.28Neutral
STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:OTX, the sentiment is Negative. The current price of 0.20 is below the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.21, and below the 200-day MA of 0.22, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 46.28 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:OTX.

Medinex Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

SG:OTX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:OTXSG:OTX78OutperformSGD 26.91M7.9319.60%8.40%-3.11%-21.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%25%50%75%SG:OTXSG:1J5SG:40TSG:505SG:546SG:MIJDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SG:OTX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:OTXMedinex Ltd.0.20-0.02-10.31%
SG:1J5Hyphens Pharma International Ltd.0.350.012.94%
SG:40TISEC Healthcare Ltd0.310.000.32%
SG:505Asiamedic Limited0.02-0.00-10.00%
SG:546Medtecs International Corporation Ltd.0.10-0.02-17.89%
SG:MIJAlliance Healthcare Group Ltd.0.180.0762.16%

Medinex Ltd. Corporate Events

Medinex Shareholders Back Dividend, Board Line-Up and Share Issue Mandate at 2026 AGM

Aug 18, 2026

Medinex Ltd. reported the outcomes of its 24 July 2026 annual general meeting in Singapore, where shareholders unanimously approved a final tax-exempt dividend of S$0.0084 per share for the financial year ended 31 March 2026 and endorsed directors’ f...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 14, 2026